(RTTNews) - Harmony Biosciences Holdings, Inc. (HRMY), a biopharmaceutical company, on Monday announced that Senior Executive Vice President and Chief Operating Officer Peter Anastasiou will become President and CEO and join the Board, effective January 1, 2027.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.